C FIN INT INV (00721) Swings to HK$3.70 million Interim Loss; NAV Per Share Rises to 1.48 HK Cents

Bulletin Express03-12

China Financial International Investments Limited (“C FIN INT INV”, 00721) reported an unaudited loss attributable to shareholders of HK$3.70 million for the six months ended 31 December 2025, reversing a profit of HK$1.64 million in the prior-year period.

Key financial items

• Revenue dropped to nil from HK$0.16 million; the prior period’s revenue comprised dividend income from listed securities.

• Fair-value gains on financial assets at FVTPL rose 159.6 % to HK$2.96 million, while other gains of HK$3.68 million booked last year did not recur.

• Administrative expenses more than doubled to HK$6.23 million, becoming the principal driver of the loss.

• Finance costs remained stable at HK$0.42 million.

Balance-sheet highlights

• Total assets stood at HK$178.94 million, down 1.36 % versus 30 June 2025.

• Net assets increased 3.31 % to HK$162.45 million on the back of HK$6.29 million of other comprehensive income, mainly from exchange-rate movements and fair-value gains on FVTOCI instruments.

• Net asset value per share improved to 1.48 HK cents from 1.43 HK cents at the previous fiscal year-end.

• Cash and cash equivalents totalled HK$89.62 million, compared with HK$96.48 million at 30 June 2025; the current ratio strengthened to 7.21 times (30 June 2025: 5.11 times).

Investment portfolio

• Listed securities (held for trading and FVTOCI) were valued at HK$44.80 million, representing 25.03 % of total assets.

• Unlisted equity investments at FVTPL and FVTOCI carried a combined fair value of HK$42.66 million, equivalent to 23.84 % of total assets. Clean-energy holdings accounted for HK$28.42 million of this amount.

Capital structure and liquidity

• The Group maintained an unsecured bond liability of HK$10.00 million maturing 30 June 2026 at 8 % coupon; no bank borrowings were reported.

• Gearing ratio (total liabilities/total assets) declined to 9.21 % from 13.33 %.

• A total of 1.00 billion share options were granted on 28 November 2025, resulting in HK$2.62 million of share-based payment expense.

Dividend

• The Board did not declare an interim dividend.

Outlook

• Management reaffirmed strategic focus on China’s bioenergy sector and signalled plans to exit legacy micro-loan investments while continuing to monitor operating costs and risk exposure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment